Objective
Four predoctoral positions (6 months - 1 year) are available to perform research as part of a doctoral thesis in the Anti-HIV Therapy Group of the Rega Institute of the KU Leuven, Belgium. This group aims at developing new antiviral compounds for the treatment of AIDS patients. The Rega Institute has a world-wide reputation in AIDS research, especially in antiviral drug design, in determination of the mechanism of anti- HIV action of new compounds and in evaluation and follow up of development of in vitro resistance. Recently our research effort has focused on new antiviral targets, namely HN entry and integration. Doctoral research students who have synthesized new compounds can benefit to great extent from the possibility to evaluate the potential inhibitory effect of their compounds against the replication of HIV in cell culture. Students who study compounds with known anti-HIV activity can profit from the identification of the mechanism of action of their compound. Students who study viral entry or viral integration or antiviral drug resistance in general can use our wide collection of established drugs and HIV strains as well as our proprietary novel technology focusing on HIV entry or integration. Doctoral students will be trained in the different aspects of HIV research and anti- HIV chemotherapy. Special attention will be given to the biosafety training (BL-3 for infectious HIV cell culture work). Skills and techniques trained include: cell culture work; virology (titration, microscopy of cytopathic effect, ultra-centrifugation, time-of -addition experiments, drug-resistance selection, p24 ELISA); and chimeric virus technology (CVT) to elucidate the gene responsible for the reduced sensitivity of the selected strain (cloning, PCR, sequencing, transfection). Students will be trained in enzymatic assays (integrase, reverse transcriptase, protease) and cell culture assays based on reporter gene activity measurement (transactivation, Rev, integrase).
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences biological sciences microbiology virology
- medical and health sciences basic medicine medicinal chemistry
- medical and health sciences health sciences infectious diseases RNA viruses HIV
- medical and health sciences basic medicine pharmacology and pharmacy drug resistance
- medical and health sciences basic medicine pharmacology and pharmacy pharmaceutical drugs antivirals
You need to log in or register to use this function
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Data not available
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Data not available
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
3000 LOUVAIN / LEUVEN
Belgium
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.